How Derek Lowe made a blog about drug development popular

“I’m a short-term pessimist and a long-term optimist” about the potential for AI to transform drug development, Derek Lowe, author of the In the Pipeline blog, told BioCentury.

His skepticism about claims that AI will rapidly transform the field is driven by a belief that the “problems that we have in the drug industry that we want to solve are almost inversely proportional to the ability of AI to solve them,” Lowe said in an interview with The BioCentury Show. “The really, really hard stuff, picking targets and anticipating human tox” aren’t going to be solved by AI any time soon, he predicted...